Clinical Trials on Fluid Volume Excess in Japan
Total 10 results
-
Fresenius Kabi JapanCompletedPlasma Volume Substitution (Hypovolemia) Including Massive HemorrhageJapan
-
Otsuka Pharmaceutical Co., Ltd.RecruitingPediatric Congestive Heart Failure (CHF) Patients With Volume OverloadJapan
-
Tokyo UniversityNot yet recruitingPancreatitis | Pancreatic Pseudocyst | Pancreatic Fluid CollectionJapan
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
National Hospital Organization Minami Kyoto HospitalRecruitingChronic Respiratory Failure | Exercise Capacity | High-flow Nasal Cannula | Optimal SpO2 ValueJapan
-
AO Innovation Translation CenterAO Foundation, AO SpineRecruitingSpinal Column TumorUnited States, Canada, Italy, Australia, China, Germany, Hungary, Japan, United Kingdom
-
Tokyo UniversityRecruitingPancreatic Pseudocyst | Pancreatitis, Acute Necrotizing | Walled-off Necrosis | Pancreatic Fluid CollectionJapan
-
Kenichiro YamagataCompletedAtrial Fibrillation | Peripheral Vascular Disease | Vascular Access ComplicationsCzechia, Japan
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan